Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 3, 2011, Pages 420-424

  Fiorelli, Alfonso ^a   Vicidomini, Giovanni ^a   Di Domenico, Marina ^a   Napolitano, Filomena ^a   Messina, Gaetana ^a   Morgillo, Floriana ^a   Ciardiello, Fortunato ^a   Santini, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Exudate; Pleural effusion; Vascular endothelial grow factor

Indexed keywords

AMYLASE; GLUCOSE; LACTATE DEHYDROGENASE; VASCULOTROPIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PNEUMONIA; BENIGN TUMOR; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; LIVER CIRRHOSIS; LUNG CANCER; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NEPHROTIC SYNDROME; PLEURA EFFUSION; PLEURA FLUID; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; THORACOCENTESIS; TUBERCULOSIS; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE; HUMANS; ITALY; L-LACTATE DEHYDROGENASE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARACENTESIS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79952347899     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.250357     Document Type: Article

References (15)

1. Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures. Eur J Cardiothor Surg 2008;33:723-727.
2. Hernandez L, Espasa A, Fernandez C, Candela A, Martin C, Romero S. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion. Lung Cancer 2002;36:83-89.
3. Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB, Ellis LM. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Clin Cancer Res 1999;5;3364-3368.
4. Light RW, Mac Gregor MI, Luchsinger PC, Ball WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507.
5. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmè D, Gasti G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-187.
6. Thickett DR, Armstrong L, Millar AB. Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 1999;54:707-10.
7. Yanagawa H, Takeuchi E, Suzuki Y, Ohmoto Y, Bando H, Sone S. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother 1999;48:396-400.
8. Kaya A, Poyraz B, Celik G, Ciledag A, Gulbay BE, Savas H, Savas I. Vascular endothelial growth factor in benign and malignant pleural effusions. Arch Bronconeumol 2005;41:376-379.
9. Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M, Louis R. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions. Respir Med 2008;102;1708-1714.
10. Shu J, Sun G, Liu H, Liu J. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusion. Acta Oncologica 2007;46:1004-1011.
11. Sack U, Hoffmann M, Zhao XJ, Chan KS, Hui DSC, Gosse H, Engelmann J, Schauer J, Emmrich F, Hoheisel G. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 2005;25:600-604.
12. Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001;281:L119-L125.
13. Verheul HMW, Hoekman K, Jorna AS, Smit EF, Pinedo HM. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formations. Oncologist 2000;5:45-50.
14. San Jose ME, Alvarez D, Valdes L, Sarandeses A, Valle JM, Penela P. Utility of tumor markers in the diagnosis of neoplastic pleural effusion. Clinica Chimica Acta 1997;265:193-205.
15. Ferrer J, Roldan J, Teixidor J, Pallisa E, Gich I, Morell F. Predictors of pleural malignancy in patients with pleural effusion undergoing thora-coscopy. Chest 2005;127:1017-22.